The vaccine the second approved for use in the U.S. behind Pfizer and BioNTech s is Moderna s first-ever FDA authorized product. The agency s authorization kickstarts the federal government s plan to distribute roughly 5.9 million doses of Moderna s vaccine to 64 states, territories and major cities across the nation next week.
Initial doses will be limited as manufacturing ramps up, with officials predicting it will take months to immunize everyone in the U.S. who wants to be vaccinated. U.S. officials hope to vaccinate at least 20 million Americans mostly front-line health-care workers and nursing home residents by the end of the year.
The vaccine the second approved for use in the U.S. behind Pfizer and BioNTech s is Moderna s first-ever FDA authorized product. The agency s authorization kickstarts the federal government s plan to distribute roughly 5.9 million doses of Moderna s vaccine to 64 states, territories and major cities across the nation next week.
Initial doses will be limited as manufacturing ramps up, with officials predicting it will take months to immunize everyone in the U.S. who wants to be vaccinated. U.S. officials hope to vaccinate at least 20 million Americans mostly front-line health-care workers and nursing home residents by the end of the year.
The vaccine the second approved for use in the U.S. behind Pfizer and BioNTech s is Moderna s first-ever FDA authorized product. The agency s authorization kickstarts the federal government s plan to distribute roughly 5.9 million doses of Moderna s vaccine to 64 states, territories and major cities across the nation next week.
Initial doses will be limited as manufacturing ramps up, with officials predicting it will take months to immunize everyone in the U.S. who wants to be vaccinated. U.S. officials hope to vaccinate at least 20 million Americans mostly front-line health-care workers and nursing home residents by the end of the year.
The vaccine the second approved for use in the U.S. behind Pfizer and BioNTech s is Moderna s first-ever FDA authorized product. The agency s authorization kickstarts the federal government s plan to distribute roughly 5.9 million doses of Moderna s vaccine to 64 states, territories and major cities across the nation next week.
Initial doses will be limited as manufacturing ramps up, with officials predicting it will take months to immunize everyone in the U.S. who wants to be vaccinated. U.S. officials hope to vaccinate at least 20 million Americans mostly front-line health-care workers and nursing home residents by the end of the year.
White House chief of staff Mark Meadows told FDA Commissioner Stephen Hahn to submit his resignation if the agency doesn t clear Pfizer s coronavirus vaccine for emergency use by the end of the day Friday, according to multiple reports.
The warning led the FDA to accelerate its timetable for clearing America s first Covid-19 vaccine from Saturday morning to later Friday, according to the Washington Post, which cited anonymous sources. This is an untrue representation of the phone call with the Chief of Staff, Hahn told CNBC in a statement. The FDA was encouraged to continue working expeditiously on Pfizer-BioNTech s EUA request. FDA is committed to issuing this authorization quickly, as we noted in our statement this morning.